Clinical Trial Update: Study of Neoadjuvant Regimen for Radioactive Iodine Treatment of Metastatic and Advanced Differentiated Thyroid Cancers [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a neoadjuvant regimen for radioactive iodine treatment in metastatic and advanced differentiated thyroid cancers; status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Differentiated Thyroid Cancer
• Thyroid Cancer

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: Thyroid, Metastasis | Phase 2 | Status: UNKNOWN